Bicycle Therapeutics plc (BCYC)

Import this data to Google Sheets with:

=jivedata("BCYC","financials")

Full statements spill as a table. For one cell: =jivedata("BCYC","Revenue") or =jivedata("BCYC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Bicycle Therapeutics plc

BCYC • CIK 0001761612

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$26,976	$35,275	$72,586	$61,205
Operating Income (Loss)	$-189,946	$-209,872	$-247,065	$-210,300
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-179,207	$-173,796	$-218,808	$-188,680
Income Tax Expense (Benefit)	$1,457	$-4,765	$152	$1,732
Net Income (Loss) Attributable to Parent	$-180,664	$-169,031	$-218,960	$-190,412
Weighted Average Number of Shares Outstanding, Basic	35,592,362	58,207,593	69,279,838	69,799,694
Research and Development Expense	$156,496	$172,966	$240,283	$200,257
General and Administrative Expense	$60,426	$72,181	$79,368	$71,248
Operating Expenses	$216,922	$245,147	$319,651	$271,505
Interest and Other Income	$14,002	$34,284	$28,463	$21,813
InterestExpenseNonoperating	—	$1,730	$206	$193
Gain (Loss) on Extinguishment of Debt	—	$-954	$-954	$-954
Nonoperating Income (Expense)	$10,739	$36,076	$28,257	$21,620
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-182,355	$-167,608	$-222,584	$-192,465
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	$-1,691	$1,423	$-3,624	$-2,053

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$526,423	$879,520	$628,110	$510,052
Prepaid Expense and Other Assets, Current	$11,406	$13,432	$19,181	$17,765
Property, Plant and Equipment, Net	$14,515	$9,516	$6,021	$4,695
Operating Lease, Right-of-Use Asset	$13,169	$7,673	$15,886	$13,979
Assets, Current	$561,868	$928,605	$682,885	$575,236
Other Assets, Noncurrent	$5,792	$11,074	$12,805	$12,668
Assets	$595,344	$956,868	$717,597	$606,578
Operating Lease, Liability, Noncurrent	$9,382	$3,990	$14,096	$13,680
Deferred Revenue, Noncurrent	$110,216	$91,467	$35,508	$34,077
Other Liabilities, Noncurrent	$4,579	$1,121	$1,032	$931
Liabilities	$224,412	$163,808	$107,620	$96,323
Accounts Payable, Current	$13,050	$15,793	$9,669	$5,662
Accrued Liabilities, Current	$31,509	$41,246	$44,354	$39,094
Deferred Revenue, Current	$24,978	$10,191	$2,961	$2,879
Liabilities, Current	$69,537	$67,230	$56,984	$47,635
Common Stock, Value, Issued	$550	$890	$894	$900
Additional Paid in Capital	$883,446	$1,472,842	$1,512,339	$1,525,680
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-1,304	$119	$-3,505	$-5,416
Retained Earnings (Accumulated Deficit)	$-511,760	$-680,791	$-899,751	$-1,010,909
Stockholders' Equity Attributable to Parent	$370,932	$793,060	$609,977	$510,255
Common Stock, Shares Authorized	59,612,613	155,876,645	159,685,229	163,361,109
Common Stock, Shares, Issued	42,431,766	69,061,418	69,367,896	69,814,145

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-180,664	$-169,031	$-218,960	$-190,412
Net Cash Provided by (Used in) Operating Activities	$-60,628	$-164,724	$-249,675	$-206,050
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$1,346	$-694	$804	$-3,464
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$187,816	$353,097	$-251,352	$-211,889
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$526,970	$880,067	$628,715	$395,274
Share-based Payment Arrangement, Noncash Expense	$32,477	$38,081	$39,464	$33,758
Payments to Acquire Property, Plant, and Equipment	$2,929	$1,235	$2,350	$2,226
Depreciation, Depletion and Amortization	$6,546	$7,174	$6,422	$5,288
Net Cash Provided by (Used in) Investing Activities	$-2,929	$-1,235	$-2,350	$-2,226
Gain (Loss) on Extinguishment of Debt	—	$-954	$-954	$-954
Deferred Income Tax Expense (Benefit)	$3,306	$-5,226	$-850	$882
Other Noncash Expense	$661	$1,036	$1,036	$1,036
Repayments of Long-term Debt	—	$31,863	$31,863	$31,863
Proceeds from Issuance of Common Stock	$249,345	$544,127	$544,127	$544,127
Proceeds from Stock Options Exercised	$682	$7,528	$37	$47
Finance Lease, Principal Payments	—	$42	$168	$196
Net Cash Provided by (Used in) Financing Activities	$250,027	$519,750	$-131	$-149
Cash and Cash Equivalents, at Carrying Value	$526,423	$879,520	$628,110	$394,611
Restricted Cash Equivalents, Current	—	—	$547	$547
Restricted Cash and Cash Equivalents, Noncurrent	—	—	$58	$-431
Interest Paid, Excluding Capitalized Interest, Operating Activities	$2,753	$1,373	$1,373	$1,373
Finance Lease, Interest Payment on Liability	—	$23	$78	$77
Income Taxes Paid, Net	$562	$792	$-717	$810
Operating Lease, Payments	$5,595	$5,785	$5,957	$5,469
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$3,898	$3,898	$12,383	$12,383
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	—	$1,102	$1,102	$1,102
Increase (Decrease) in Accounts Receivable	$-2,482	$-2,482	$-2,482	—
Increase (Decrease) in Prepaid Expense and Other Assets	$2,072	$2,044	$5,816	$-3,415
Increase (Decrease) in Accounts Payable	$8,002	$3,095	$-6,871	$-11,848
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$2,398	$9,698	$4,093	$171
IncreaseDecreaseInOperatingLeaseLiability	$-4,109	$-4,888	$-5,456	$-4,794
Increase (Decrease) in Deferred Revenue	$68,951	$-31,952	$-69,190	$-57,688
Increase (Decrease) in Other Noncurrent Liabilities	$509	$189	$189	$189

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("BCYC","financials")

Full statements spill as a table. For one cell: =jivedata("BCYC","Revenue") or =jivedata("BCYC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.